Operating Expenses Endring Dato
AbbVie USD 11.11B 540M 2023-12
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
Amgen USD 6.93B 2.11B 2023-12
Baxter International USD 3.59B 173M 2023-12
Biogen USD 2.03B 344.1M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Eli Lilly USD 6.97B 2.08B 2023-12
Fujifilm JPY 654.38B 45.84B 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Ironwood Pharmaceuticals USD 79.96M 6.25M 2023-12
Merck USD 16.56B 6.35B 2023-12
Myriad Genetics USD 228M 24M 2023-12
Pacira USD 148.08M 1.87M 2023-12
Perrigo USD 1.06B 74.6M 2023-09
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Revance Therapeutics USD 196.07M 72.44M 2023-09
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09
Xencor USD 79.7M 2.27M 2023-12
Zoetis USD 1.56B 129M 2023-12



Coherus Biosciences Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.